Skip to nav Skip to content
Jiandong  Chen

Jiandong Chen, PhD

Program: Molecular Oncology

Research Program: Cancer Biology & Evolution Program

Contact

  • Overview

    Our laboratory mainly focuses on studying the p53 pathway in tumor cells.

    Associations

    • Molecular Oncology
    • Lung Cancer Center of Excellence
    • Cancer Biology & Evolution Program
    • Molecular Oncology & Drug Discovery Program

    Education & Training

    Graduate:

    • University of Pittsburgh, PhD - Molecular Biology

    Fellowship:

    • Princeton University - Molecular Biology
  • Research Interest

    Our laboratory mainly focuses on studying the p53 pathway in tumor cells. Recent work involve the p53 regulator MDMX. We are investigating the regulation of MDMX by ubiquitination and phosphorylation, the roles of MDMX in regulating p53 response to DNA damage and ribosomal stress, and the role of MDMX in tumor formation. We are also trying to develop inhibitors against MDM2 and MDMX as therapeutic agents. A second area of research addresses the role of SirT1 in stress response in tumor cells, regulation of SirT1 expression by E2F1, and the role of SirT1 phosphorylation.

  • Publications

    • Fenton M, Borcherds W, Chen L, Anbanandam A, Levy R, Chen J, Daughdrill G. The MDMX Acidic Domain Uses Allovalency to Bind Both p53 and MDMX. J Mol Biol. 2022 Nov.434(22):167844. Pubmedid: 36181774. Pmcid: PMC9644833.
    • Karim RM, Yang L, Chen L, Bikowitz MJ, Lu J, Grassie D, Shultz ZP, Lopchuk JM, Chen J, Schönbrunn E. Discovery of Dual TAF1-ATR Inhibitors and Ligand-Induced Structural Changes of the TAF1 Tandem Bromodomain. J Med Chem. 2022 Mar.65(5):4182-4200. Pubmedid: 35191694.
    • Sang P, Shi Y, Lu J, Chen L, Yang L, Borcherds W, Abdulkadir S, Li Q, Daughdrill G, Chen J, Cai J. Correction to α-Helix-Mimicking Sulfono-γ-AApeptide Inhibitors for p53-MDM2/MDMX Protein-Protein Interactions. J Med Chem. 2020 Sep.63(17):10087. Pubmedid: 32822169. Pmcid: PMC7853636.
    • Shi Y, Sang P, Lu J, Higbee P, Chen L, Yang L, Odom T, Daughdrill G, Chen J, Cai J. Rational Design of Right-Handed Heterogeneous Peptidomimetics as Inhibitors of Protein-Protein Interactions. J Med Chem. 2020 Nov.63(21):13187-13196. Pubmedid: 33140956. Pmcid: PMC8170677.
    • Huang Q, Chen L, Schonbrunn E, Chen J. MDMX inhibits casein kinase 1α activity and stimulates Wnt signaling. Embo J. 2020 Jul.39(14):e104410. Pubmedid: 32511789. Pmcid: PMC7361285.
    • Li Q, Karim RM, Cheng M, Das M, Chen L, Zhang C, Lawrence HR, Daughdrill GW, Schonbrunn E, Ji H, Chen J. Inhibition of p53 DNA binding by a small molecule protects mice from radiation toxicity. Oncogene. 2020 Jul.39(29):5187-5200. Pubmedid: 32555331. Pmcid: PMC7398576.
    • Liu X, Huang Q, Chen L, Zhang H, Schonbrunn E, Chen J. Tumor-derived CK1α mutations enhance MDMX inhibition of p53. Oncogene. 2020 Jan.39(1):176-186. Pubmedid: 31462704. Pmcid: PMC7739390.
    • Sang P, Shi Y, Lu J, Chen L, Yang L, Borcherds W, Abdulkadir S, Li Q, Daughdrill GW, Chen J, Cai J. α-Helix-Mimicking Sulfono-γ-AApeptide Inhibitors for p53-MDM2/MDMX Protein-Protein Interactions. J Med Chem. 2020 Feb.63(3):975-986. Pubmedid: 31971801. Pmcid: PMC7025332.
    • Sang P, Shi Y, Higbee P, Wang M, Abdulkadir S, Lu J, Daughdrill GW, Chen J, Cai J. Rational Design and Synthesis of Right-Handed d-Sulfono-γ-AApeptide Helical Foldamers as Potent Inhibitors of Protein-Protein Interactions. J Org Chem. 2020 Aug.85(16):10552-10560. Pubmedid: 32700908. Pmcid: PMC8204676.
    • Yang L, Song T, Cheng Q, Chen L, Chen J. Mutant p53 Sequestration of the MDM2 Acidic Domain Inhibits E3 Ligase Activity. Mol Cell Biol. 2019 Feb.39(4). Pubmedid: 30455251. Pmcid: PMC6362316.
    • He F, Borcherds W, Song T, Wei X, Das M, Chen L, Daughdrill GW, Chen J. Interaction between p53 N terminus and core domain regulates specific and nonspecific DNA binding. Proc Natl Acad Sci U S A. 2019 Apr.116(18):8859-8868. Pubmedid: 30988205. Pmcid: PMC6500136.
    • Huang Q, Chen L, Yang L, Xie X, Gan L, Cleveland JL, Chen J. MDMX acidic domain inhibits p53 DNA binding in vivo and regulates tumorigenesis. Proc Natl Acad Sci U S A. 2018 Apr.115(15):E3368-E3377. Pubmedid: 29581299. Pmcid: PMC5899450.
    • Borcherds W, Becker A, Chen L, Chen J, Chemes LB, Daughdrill GW. Optimal Affinity Enhancement by a Conserved Flexible Linker Controls p53 Mimicry in MdmX. Biophys J. 2017 May.112(10):2038-2042. Pubmedid: 28487147. Pmcid: PMC5443996.
    • Yang L, Fang J, Chen J. Tumor cell senescence response produces aggressive variants. Cell Death Discov. 2017 Aug.3:17049. Pubmedid: 28845296. Pmcid: PMC5563524.
    • Chen J. The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression. Cold Spring Harb Perspect Med. 2016 Mar.6(3):a026104. Pubmedid: 26931810. Pmcid: PMC4772082.
    • Chen J. Intra molecular interactions in the regulation of p53 pathway. Transl Cancer Res. 2016 Dec.5(6):639-649. Pubmedid: 30613472. Pmcid: PMC6319914.
    • Sun L, Kokura K, Izumi V, Koomen JM, Seto E, Chen J, Fang J. MPP8 and SIRT1 crosstalk in E-cadherin gene silencing and epithelial-mesenchymal transition. EMBO Rep. 2015 Jun.16(6):689-699. Pubmedid: 25870236. Pmcid: PMC4467853.
    • Yang L, Song T, Chen L, Soliman H, Chen J. Nucleolar repression facilitates initiation and maintenance of senescence. Cell Cycle. 2015 Dec.14(22):3613-3623. Pubmedid: 26505814. Pmcid: PMC4825723.
    • Chen L, Borcherds W, Wu S, Becker A, Schonbrunn E, Daughdrill GW, Chen J. Autoinhibition of MDMX by intramolecular p53 mimicry. Proc Natl Acad Sci U S A. 2015 Apr.112(15):4624-4629. Pubmedid: 25825738. Pmcid: PMC4403185.
    • Peng L, Yuan Z, Li Y, Ling H, Izumi V, Fang B, Fukasawa K, Koomen J, Chen J, Seto E. Ubiquitinated sirtuin 1 (SIRT1) function is modulated during DNA damage-induced cell death and survival. J Biol Chem. 2015 Apr.290(14):8904-8912. Pubmedid: 25670865. Pmcid: PMC4423681.
    • Zhang M, Xiang S, Joo HY, Wang L, Williams KA, Liu W, Hu C, Tong D, Haakenson J, Wang C, Zhang S, Pavlovicz RE, Jones A, Schmidt KH, Tang J, Dong H, Shan B, Fang B, Radhakrishnan R, Glazer PM, Matthias P, Koomen J, Seto E, Bepler G, Nicosia SV, Chen J, Li C, Gu L, Li GM, Bai W, Wang H, Zhang X. HDAC6 deacetylates and ubiquitinates MSH2 to maintain proper levels of MutSα. Mol Cell. 2014 Jul.55(1):31-46. Pubmedid: 24882211. Pmcid: PMC4188514.
    • Zheng H, Chen L, Pledger WJ, Fang J, Chen J. p53 promotes repair of heterochromatin DNA by regulating JMJD2b and SUV39H1 expression. Oncogene. 2014 Feb.33(6):734-744. Pubmedid: 23376847. Pmcid: PMC3912226.
    • Schneeberger VE, Luetteke N, Ren Y, Berns H, Chen L, Foroutan P, Martinez GV, Haura EB, Chen J, Coppola D, Wu J. SHP2E76K mutant promotes lung tumorigenesis in transgenic mice. Carcinogenesis. 2014 Aug.35(8):1717-1725. Pubmedid: 24480804. Pmcid: PMC4123642.
    • Cheng Q, Song T, Chen L, Chen J. Autoactivation of the MDM2 E3 ligase by intramolecular interaction. Mol Cell Biol. 2014 Aug.34(15):2800-2810. Pubmedid: 24842904. Pmcid: PMC4135571.
    • Yang L, Chen J. SirT1 and rRNA in the nucleolus: regulating the regulator. Oncoscience. 2014.1(2):111-112. Pubmedid: 25594003. Pmcid: PMC4278288.
    • Yang L, Song T, Chen L, Kabra N, Zheng H, Koomen J, Seto E, Chen J. Regulation of SirT1-nucleomethylin binding by rRNA coordinates ribosome biogenesis with nutrient availability. Mol Cell Biol. 2013 Oct.33(19):3835-3848. Pubmedid: 23897426. Pmcid: PMC3811878.
    • Gray JE, Altiok S, Alexandrow MG, Walsh FW, Chen J, Schell MJ, Tai DF, Bepler G. Phase 2 randomized study of enzastaurin (LY317615) for lung cancer prevention in former smokers. Cancer. 2013 Mar.119(5):1023-1032. Pubmedid: 23065656. Pmcid: PMC3578040.
    • Song T, Yang L, Kabra N, Chen L, Koomen J, Haura EB, Chen J. The NAD+ synthesis enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT1) regulates ribosomal RNA transcription. J Biol Chem. 2013 Jul.288(29):20908-20917. Pubmedid: 23737528. Pmcid: PMC3774361.
    • Zheng H, Yang L, Peng L, Izumi V, Koomen J, Seto E, Chen J. hMOF acetylation of DBC1/CCAR2 prevents binding and inhibition of SirT1. Mol Cell Biol. 2013 Dec.33(24):4960-4970. Pubmedid: 24126058. Pmcid: PMC3889553.
    • Hodul PJ, Dong Y, Husain K, Pimiento JM, Chen J, Zhang A, Francois R, Pledger WJ, Coppola D, Sebti SM, Chen DT, Malafa MP. Vitamin E δ-tocotrienol induces p27(Kip1)-dependent cell-cycle arrest in pancreatic cancer cells via an E2F-1-dependent mechanism. PLoS One. 2013 Aug.8(2):e52526. Pubmedid: 23393547. Pmcid: PMC3564846.
    • Tang J, Agrawal T, Cheng Q, Qu L, Brewer MD, Chen J, Yang X. Phosphorylation of Daxx by ATM contributes to DNA damage-induced p53 activation. PLoS One. 2013 Aug.8(2):e55813. Pubmedid: 23405218. Pmcid: PMC3566025.
    • Chen J. The Roles of MDM2 and MDMX Phosphorylation in Stress Signaling to p53. Genes Cancer. 2012 Mar.3(3-4):274-282. Pubmedid: 23150760. Pmcid: PMC3494364.
    • Peng L, Ling H, Yuan Z, Fang B, Bloom G, Fukasawa K, Koomen J, Chen J, Lane WS, Seto E. SIRT1 negatively regulates the activities, functions, and protein levels of hMOF and TIP60. Mol Cell Biol. 2012 Jul.32(14):2823-2836. Pubmedid: 22586264. Pmcid: PMC3416197.
    • Wu S, Chen L, Becker A, Schonbrunn E, Chen J. Casein kinase 1α regulates an MDMX intramolecular interaction to stimulate p53 binding. Mol Cell Biol. 2012 Dec.32(23):4821-4832. Pubmedid: 23028042. Pmcid: PMC3497597.
    • Li X, Gilkes D, Li B, Cheng Q, Pernazza D, Lawrence N, Chen J. Abnormal MDMX degradation in tumor cells due to ARF deficiency. Oncogene. 2012 Aug.31(32):3721-3732. Pubmedid: 22120712. Pmcid: PMC3290737.
    • Cross B, Chen L, Cheng Q, Li B, Yuan ZM, Chen J. Inhibition of p53 DNA binding function by the MDM2 protein acidic domain. J Biol Chem. 2011 May.286(18):16018-16029. Pubmedid: 21454483. Pmcid: PMC3091211.
    • Hu Y, Li X, Sebti SM, Chen J, Cai J. Design and synthesis of AApeptides: a new class of peptide mimics. Bioorg Med Chem Lett. 2011 Mar.21(5):1469-1471. Pubmedid: 21292484.
    • Madden MM, Muppidi A, Li Z, Li X, Chen J, Lin Q. Synthesis of cell-permeable stapled peptide dual inhibitors of the p53-Mdm2/Mdmx interactions via photoinduced cycloaddition. Bioorg Med Chem Lett. 2011 Mar.21(5):1472-1475. Pubmedid: 21277201. Pmcid: PMC3057119.
    • Peng L, Yuan Z, Ling H, Fukasawa K, Robertson K, Olashaw N, Koomen J, Chen J, Lane WS, Seto E. SIRT1 deacetylates the DNA methyltransferase 1 (DNMT1) protein and alters its activities. Mol Cell Biol. 2011 Dec.31(23):4720-4734. Pubmedid: 21947282. Pmcid: PMC3232929.
    • Cheng Q, Chen J. The phenotype of MDM2 auto-degradation after DNA damage is due to epitope masking by phosphorylation. Cell Cycle. 2011 Apr.10(7):1162-1166. Pubmedid: 21386656. Pmcid: PMC3100889.
    • Kim D, Sun M, He L, Zhou QH, Chen J, Sun XM, Bepler G, Sebti SM, Cheng JQ. A small molecule inhibits Akt through direct binding to Akt and preventing Akt membrane translocation. J Biol Chem. 2010 Mar.285(11):8383-8394. Pubmedid: 20068047. Pmcid: PMC2832988.
    • Yuan Z, Villagra A, Peng L, Coppola D, Glozak M, Sotomayor EM, Chen J, Lane WS, Seto E. The ATDC (TRIM29) protein binds p53 and antagonizes p53-mediated functions. Mol Cell Biol. 2010 Jun.30(12):3004-3015. Pubmedid: 20368352. Pmcid: PMC2876676.
    • Phan J, Li Z, Kasprzak A, Li B, Sebti S, Guida W, Schönbrunn E, Chen J. Structure-based design of high affinity peptides inhibiting the interaction of p53 with MDM2 and MDMX. J Biol Chem. 2010 Jan.285(3):2174-2183. Pubmedid: 19910468. Pmcid: PMC2804373.
    • Zhang Y, Dong H, Li Z, Xiang S, Zhu Y, Zhang M, Liu J, Bai W, Nicosia SV, Chen J. Bing De Ling, a Chinese herbal formula, inhibits cancer cells growth via p53. Front Biosci (Elite Ed). 2010 Jan.2(1):221-230. Pubmedid: 20036872.
    • Cheng Q, Chen J. Mechanism of p53 stabilization by ATM after DNA damage. Cell Cycle. 2010 Feb.9(3):472-478. Pubmedid: 20081365. Pmcid: PMC2977994.
    • Chen L, Li Z, Zwolinska AK, Smith MA, Cross B, Koomen J, Yuan ZM, Jenuwein T, Marine JC, Wright KL, Chen J. MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output. Embo J. 2010 Aug.29(15):2538-2552. Pubmedid: 20588255. Pmcid: PMC2928696.
    • Li B, Cheng Q, Li Z, Chen J. p53 inactivation by MDM2 and MDMX negative feedback loops in testicular germ cell tumors. Cell Cycle. 2010 Apr.9(7):1411-1420. Pubmedid: 20372076. Pmcid: PMC3008305.
    • Fu W, Ma Q, Chen L, Li P, Zhang M, Ramamoorthy S, Nawaz Z, Shimojima T, Wang H, Yang Y, Shen Z, Zhang Y, Zhang X, Nicosia SV, Zhang Y, Pledger JW, Chen J, Bai W. MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation. J Biol Chem. 2009 May.284(21):13987-14000. Pubmedid: 19321440. Pmcid: PMC2682847.
    • Kabra N, Li Z, Chen L, Li B, Zhang X, Wang C, Yeatman T, Coppola D, Chen J. SirT1 is an inhibitor of proliferation and tumor formation in colon cancer. J Biol Chem. 2009 Jul.284(27):18210-18217. Pubmedid: 19433578. Pmcid: PMC2709385.
    • Lawrence HR, Li Z, Yip ML, Sung SS, Lawrence NJ, McLaughlin ML, McManus GJ, Zaworotko MJ, Sebti SM, Chen J, Guida WC. Identification of a disruptor of the MDM2-p53 protein-protein interaction facilitated by high-throughput in silico docking. Bioorg Med Chem Lett. 2009 Jul.19(14):3756-3759. Pubmedid: 19457663. Pmcid: PMC2754843.
    • Cheng Q, Chen L, Li Z, Lane WS, Chen J. ATM activates p53 by regulating MDM2 oligomerization and E3 processivity. Embo J. 2009 Dec.28(24):3857-3867. Pubmedid: 19816404. Pmcid: PMC2797053.
    • Yamaguchi H, Woods NT, Piluso LG, Lee HH, Chen J, Bhalla KN, Monteiro A, Liu X, Hung MC, Wang HG. p53 acetylation is crucial for its transcription-independent proapoptotic functions. J Biol Chem. 2009 Apr.284(17):11171-11183. Pubmedid: 19265193. Pmcid: PMC2670122.
    • Li Z, Chen L, Kabra N, Wang C, Fang J, Chen J. Inhibition of SUV39H1 methyltransferase activity by DBC1. J Biol Chem. 2009 Apr.284(16):10361-10366. Pubmedid: 19218236. Pmcid: PMC2667723.
    • Shaginian A, Whitby LR, Hong S, Hwang I, Farooqi B, Searcey M, Chen J, Vogt PK, Boger DL. Design, synthesis, and evaluation of an alpha-helix mimetic library targeting protein-protein interactions. J Am Chem Soc. 2009 Apr.131(15):5564-5572. Pubmedid: 19334711. Pmcid: PMC2765553.
    • Gilkes DM, Pan Y, Coppola D, Yeatman T, Reuther GW, Chen J. Regulation of MDMX expression by mitogenic signaling. Mol Cell Biol. 2008 Mar.28(6):1999-2010. Pubmedid: 18172009. Pmcid: PMC2268405.
    • Hu B, Gilkes D, Chen J. Efficient p53 Activation and Apoptosis by Simultaneous Disruption of Binding toMDM2 and MDMX. Cancer Res. 2007 Sep.67(18):8810-8817. Pubmedid: 17875722.
    • Wang C, Rauscher FJ 3rd, Cress W, Chen J. Regulation of E2F1 function by the nuclear co-repressor KAP-1. J Biol Chem. 2007 Oct.282(41):29902-9. Pubmedid: 17704056.
    • Gilkes D, Chen J. Distinct roles of MDMX in the regulation of p53 response to ribosomal stress. Cell Cycle. 2007 Jan.6(2):151-5. Epub 20. Pubmedid: 17327702.
    • Wang C, Chen L, Hou X, Li Z, Kabra N, Ma Y, Nemoto S, Finkel T, Gu W, Cress WD, Chen J. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat Cell Biol. 2006 Sep.8(9):1025-1031. Pubmedid: 16892051.
    • Gilkes DM, Chen L, Chen J. MDMX regulation of p53 response to ribosomal stress. Embo J. 2006 Nov.25(23):5614-5625. Pubmedid: 17110929. Pmcid: PMC1679771.
    • Hu B, Gilkes DM, Farooqi B, Sebti SM, Chen J. MDMX overexpression prevents p53 activation by the MDM2 inhibitor Nutlin. J Biol Chem. 2006 Nov.281(44):33030-33035. Pubmedid: 16905541.
    • Lebron C, Chen L, Gilkes DM, Chen J. Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3. Embo J. 2006 Mar.25(6):1196-1206. Pubmedid: 16511560. Pmcid: PMC1422166.
    • Wang C, Ivanov A, Chen L, Fredericks WJ, Seto E, Rauscher FJ, Chen J. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation. Embo J. 2005 Sep.24(18):3279-3290. Pubmedid: 16107876. Pmcid: PMC1224681.
    • Chen L, Gilkes DM, Pan Y, Lane WS, Chen J. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage. Embo J. 2005 Oct.24(19):3411-3422. Pubmedid: 16163388. Pmcid: PMC1276172.
    • Chen L, Yin H, Farooqi B, Sebti S, Hamilton AD, Chen J. p53 alpha-Helix mimetics antagonize p53/MDM2 interaction and activate p53. Mol Cancer Ther. 2005 Jun.4(6):1019-1025. Pubmedid: 15956260.
    • Pan Y, Chen J. Modification of MDMX by sumoylation. Biochem Bioph Res Co. 2005 Jul.332(3):702-709. Pubmedid: 15907800.
    • Chen L, Li C, Pan Y, Chen J. Regulation of p53-MDMX interaction by casein kinase 1 alpha. Mol Cell Biol. 2005 Aug.25(15):6509-6520. Pubmedid: 16024788. Pmcid: PMC1190343.
    • Wang C, Hou X, Mohapatra S, Ma Y, Cress WD, Pledger WJ, Chen J. Activation of p27Kip1 Expression by E2F1. A negative feedback mechanism. J Biol Chem. 2005 Apr.280(13):12339-12343. Pubmedid: 15713665.
    • Wang J, Gamsby J, Highfill S, Mora L, Bloom G, Yeatman T, Pan T, Ramne A, Chodosh L, Cress W, Chen J, Kerr W. Deregulated expression of LRBA facilitates cancer cell growth. Oncogene. 2004 May.23(23):4089-4097. Pubmedid: 15064745.
    • Liu Q, Kaneko S, Yang L, Feldman RI, Nicosia SV, Chen J, Cheng JQ. Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215. J Biol Chem. 2004 Dec.279(50):52175-52182. Pubmedid: 15469940.
    • Peng Y, Li C, Chen L, Sebti S, Chen J. Rescue of mutant p53 transcription function by ellipticine. Oncogene. 2003 Jul.22(29):4478-4487. Pubmedid: 12881704.
    • Wang C, Chen J. Phosphorylation and hsp90 binding mediate heat shock stabilization of p53. J Biol Chem. 2003 Jan.278(3):2066-2071. Pubmedid: 12427754.
    • Chen L, Chen J. MDM2-ARF complex regulates p53 sumoylation. Oncogene. 2003 Aug.22(34):5348-5357. Pubmedid: 12917636.
    • Pan Y, Chen J. MDM2 promotes ubiquitination and degradation of MDMX. Mol Cell Biol. 2003 Aug.23(15):5113-5121. Pubmedid: 12860999. Pmcid: PMC165735.
    • Li C, Chen L, Chen J. DNA damage induces MDMX nuclear translocation by p53-dependent and -independent mechanisms. Mol Cell Biol. 2002 Nov.22(21):7562-7571. Pubmedid: 12370303. Pmcid: PMC135668.
    • Lu W, Lin J, Chen J. Expression of p14ARF overcomes tumor resistance to p53. Cancer Res. 2002 Mar.62(5):1305-1310. Pubmedid: 11888896.
    • Li K, Wang L, Cheng J, Lu Y, Zhang L, Mou J, Hong Y, Liu Y, Duan H, Wang G, Li L, Chen J. [Mutual interaction between hepatitis C virus core protein and translin, arecombination hotspot binding protein] Chinese. Zhonghua Yi Xua Za Zhi. 2002.82:673-677. Pubmedid: 12133464.
    • Peng Y, Chen L, Li C, Lu W, Chen J. Inhibition of MDM2 by hsp90 contributes to mutant p53 stabilization. J Biol Chem. 2001 Nov.276(44):40583-40590. Pubmedid: 11507088.
    • Lu W, Chen L, Peng Y, Chen J. Activation of p53 by roscovitine-mediated suppression of MDM2 expression. Oncogene. 2001 May.20(25):3206-3216. Pubmedid: 11423970.
    • Peng Y, Chen L, Li C, Lu W, Agrawal S, Chen J. Stabilization of the MDM2 oncoprotein by mutant p53. J Biol Chem. 2001 Mar.276(9):6874-6878. Pubmedid: 11152666.
    • Lu W, Pochampally R, Chen L, Traidej M, Wang Y, Chen J. Nuclear exclusion of p53 in a subset of tumors requires MDM2 function. Oncogene. 2000 Jan.19(2):232-240. Pubmedid: 10645001.
    • Pochampally R, Li C, Lu W, Chen L, Luftig R, Lin J, Chen J. Temperature-sensitive mutants of p53 homologs. Biochem Bioph Res Co. 2000 Dec.279(3):1001-1010. Pubmedid: 11162465.
    • Pochampally R, Fodera B, Chen L, Lu W, Chen J. Activation of an MDM2-specific caspase by p53 in the absence of apoptosis. J Biol Chem. 1999 May.274(21):15271-15277. Pubmedid: 10329737.
    • Zeng X, Chen L, Jost C, Maya R, Kaelin W, Oren M, Chen J, Lu H. MDM2 supresses p73 function without promoting p73 degradation. Mol Cell Biol. 1999 May.19(5):3257-3266. Pubmedid: 10207051.
    • Chen L, Lu W, Agrawal S, Zhou W, Zhang R, Chen J. Ubiquitous induction of wild type p53 in tumor cells by antisense inhibition of MDM2 expression. Mol Med. 1999 Jan.5(1):21-34. Pubmedid: 10072445.
    • Pochampally R, Fodera B, Chen L, Shao W, Levine E, Chen J. A 60 kd MDM2 isoform is produced by caspase cleavage in non-apoptotic tumor cells. Oncogene. 1998 Nov.17(20):2629-2636. Pubmedid: 9840926 .
    • Chen L, Agrawal S, Zhou W, Zhang R, Chen J. Synergistic activation of p53 by inhibitation of mdm2 expression and DNA damage. Proc Natl Acad Sci U S A. 1998.95:195-200. Pubmedid: 9419352.
    • Chen L, Marechal V, Moreau J, Levine A, Chen J. Proteolytic cleavage of the mdm2 oncoprotein during apoptosis. J Biol Chem. 1997.272:22966-22973. Pubmedid: 9278461.
    • Chen J, Wu X, Lin J, Levine A. Mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol Cell Biol. 1996.16:2445-2452. Pubmedid: 8628312.
    • Chen J, Lin J, Levine A. Regulation of transcription functions of the p53 tumor supressor by the mdm-2 oncogene. Mol Med. 1995.1:142-152. Pubmedid: 8529093.
    • Horikoshi N, Usheva A, Chen J, Levine A, Weinmann R, Shenk T. Two domains on p53 interat with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression. Mol Cell Biol. 1995.15:227-234. Pubmedid: 7799929.
    • Xiao Z, Chen J, Levine A, Modjtahedi N, Xing J, Sellers W, Livingston D. Interation between the retinoblastoma protein and the oncoprotein. Nature. 1995.375:694-698. Pubmedid: 7791904.
  • Grants

    • Title: Selective Targeting of TAF1 Function in Acute Myeloid Leukemia
      Sponsor: Nat Institutes of Health
      PI (Contact): Schonbrunn, E., PI (MPI): Chen, J., PI (MPI): Lopchuk, J.
    • Title: Targeting Wnt Signaling Pathway
      Sponsor: Nat Institutes of Health
      PI: Chen, J.
    • Title: Anti-tumor Potential of Temperature-Sensitive p53 Mutants
      Sponsor: Nat Institutes of Health
      PI (Contact): Chen, J., PI: Mann, M.
    • Title: Intrinsic Disorder Controls the Function of p53 and Other Cancer Associated IDPs
      Sponsor: Nat Institutes of Health
      PI (MPI): Chen, J.
    • Title: Allosteric Regulation of MDMX by Protein Disorder
      Sponsor: Nat Institutes of Health
      PI (Contact): Chen, J.

Find a Researcher Search